ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Clover Biopharmaceuticals Ltd. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 653.92% and Operating profit at 30.73% over the last 5 years
- The company has a negative book value of Rs 1,869.10 crore
2
Flat results in Dec 25
- CASH AND EQV(HY) Lowest at HKD 318.58 MM
- INVENTORY TURNOVER RATIO(HY) Lowest at 0 times
- DEBTORS TURNOVER RATIO(HY) Lowest at 0.17 times
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 944.90%, its profits have fallen by -6.8%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Clover Biopharmaceuticals Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Clover Biopharmaceuticals Ltd.
-100.0%
4.98
110.07%
Hang Seng Hong Kong
8.76%
0.45
19.63%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
653.92%
EBIT Growth (5y)
30.73%
EBIT to Interest (avg)
-151.92
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.30
Sales to Capital Employed (avg)
-0.03
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-1.50
EV to EBIT
-2.41
EV to EBITDA
-2.51
EV to Capital Employed
-1.03
EV to Sales
42.27
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
DEBT-EQUITY RATIO
(HY)
Lowest at 15.32 %
RAW MATERIAL COST(Y)
Fallen by -97.88% (YoY
PRE-TAX PROFIT(Q)
At HKD -113.65 MM has Grown at 87.37%
NET PROFIT(Q)
At HKD -113.65 MM has Grown at 87.37%
-3What is not working for the Company
CASH AND EQV(HY)
Lowest at HKD 318.58 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 0 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 0.17 times
Here's what is working for Clover Biopharmaceuticals Ltd.
Debt-Equity Ratio
Lowest at 15.32 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Pre-Tax Profit
At HKD -113.65 MM has Grown at 87.37%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Net Profit
At HKD -113.65 MM has Grown at 87.37%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
Raw Material Cost
Fallen by -97.88% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Clover Biopharmaceuticals Ltd.
Cash and Eqv
Lowest at HKD 318.58 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Inventory Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 0.17 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
